ACP journal club - McMaster Experts

publication venue for

Monkeypox in Montréal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak. 176:67-76. 2023
Efficacy and safety of dapagliflozin were similar in patients with type 2 DM and atherosclerotic CVD, regardless of PAD. 174:JC10-JC10. 2021
Newly prescribed canagliflozin vs. GLP-1 agonists was linked to amputation in older adults with type 2 DM and CVD. 174:JC11-JC11. 2021
Summary for Patients: Association Between Bariatric Surgery and All-Cause Mortality. 173:I-22. 2020
Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease. 171:181-181. 2019
In localized prostate cancer, radical prostatectomy and observation did not differ for mortality at 13 years. 167:JC53-JC53. 2017
Your Money or Your Patient's Life? Ransomware and Electronic Health Records. 167:587-587. 2017
David Lawrence Sackett, MD, MSc (Epidemiology), 1934–2015. 163:JC2-JC2. 2015
In hospitalized patients, an electronic alert for acute kidney injury did not differ from usual care. 162:JC6-JC6. 2015
The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA appropriateness method. 163:S1-S40. 2015
Review: In pulmonary embolism, thrombolytic therapy reduces all-cause mortality but increases major bleeding. 161:JC9-JC9. 2014
Atypical Antipsychotic Drugs and the Risk for Acute Kidney Injury and Other Adverse Outcomes in Older Adults. 161:242-242. 2014
Live kidney donation was associated with increased mortality and end-stage renal disease at 15 years. 160:JC12-JC12. 2014
Lipid Management in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2013 Clinical Practice Guideline. 160:182-189. 2014
Methylprednisolone injections reduced carpal tunnel syndrome symptoms at 10 weeks and surgery at 1 year. 160:JC11-JC11. 2014
In intermediate-risk acute PE, tenecteplase plus heparin reduced hemodynamic decompensation but increased stroke.. 161:JC8-JC8. 2014
Statin Toxicity From Macrolide Antibiotic Coprescription. 159:575-575. 2013
Patent foramen ovale closure and medical therapy did not differ for recurrence after cryptogenic stroke. 159:JC4-JC4. 2013
Review: Routine venous thromboembolism prophylaxis in hospitalized frail older patients has uncertain benefit. 159:JC9-JC9. 2013
Statin Toxicity From Macrolide Antibiotic Coprescription. 158:869-869. 2013
Review: Blood transfusions are associated with higher mortality than no or restricted transfusions in MI. 158:JC13-JC13. 2013
Adding renal dysfunction to CHADS₂did not improve prediction of stroke or systemic embolism in AF. 158:JC13-JC13. 2013
Review: Case management reduces mortality and HF readmissions in patients with HF. 158:JC11-JC11. 2013
rt-PA within 6 hours of acute ischemic stroke did not improve clinical outcomes at 6 months. 157:JC5-JC5. 2012
Review: Oseltamivir relieves symptoms but does not reduce hospitalizations in influenza. 157:JC3-JC3. 2012
Effects of Excessive Fructose Intake on Health. 156:905-905. 2012
Hypnotic drugs were associated with increased risk for mortality. 156:JC6-JC6. 2012
Review: Perioperative statins reduce perioperative MI and AF in statin-naïve patients. 156:JC6-JC6. 2012
Conflicts of Interest Ethics: Silencing Expertise in the Development of International Clinical Practice Guidelines. 156:809-809. 2012
IV salbutamol increased mortality in patients with the acute respiratory distress syndrome. 156:JC5-JC5. 2012
Inviting Patients to Read Doctors' Notes. 156:608-608. 2012
Correction: Whole-Body Vibration. 155:860-860. 2011
The Wells rule and a primary care rule were useful for ruling out deep venous thrombosis in primary care. 154:JC6-JC6. 2011
Rates of Kidney Transplantation in Nations With Presumed Consent. 154:778-778. 2011
Should Patients With Stroke Wear Compression Stockings?. 154:506-506. 2011
Update in Hematology and Oncology: Evidence Published in 2010. 154:487-487. 2011
Hormone therapy increased risk for kidney stones in healthy postmenopausal women. 154:JC3-JC3. 2011
Review: Topical nitroglycerin reduces pain during ADL in patients with chronic tendinopathies. 154:JC2-JC2. 2011
Informing the Debate: Rates of Kidney Transplantation in Nations With Presumed Consent. 153:641-641. 2010
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease. 153:23-23. 2010
Review: Evidence on the effectiveness of sodium bicarbonate regimens to prevent contrast-induced nephropathy is unclear. 152:JC5-JC5. 2010
Risk for postoperative venous thromboembolism in women was increased for ≥ 12 weeks and varied by type of surgery. 152:JC3-JC3. 2010
Adding revascularization to medical therapy did not improve renal function in atherosclerotic renal artery stenosis. 152:JC2-JC2. 2010
Guidelines and Conflicts of Interest. 153:422-422. 2010
A Mediterranean-style diet reduced need for glucose-lowering drugs more than a low-fat diet in type 2 diabetes. 151:JC6-JC6. 2009
New and underutilized features of ACP Journal Club PLUS and ACPJC.org: stellar articles, searches, and succinct synopses of the principles and practice of “personalized” evidence-based medicine. 151:JC6-JC6. 2009
Sensitive cardiac troponin assays were more accurate than a standard troponin assay for early diagnosis of AMI. 151:JC6-JC6. 2009
Systematic Review: Family History in Risk Assessment for Common Diseases. 151:878-878. 2009
The tough math of evidence-based health care: E × KT2 = ROI. 151:JC5-JC5. 2009
Correction: Predicting Deep Venous Thrombosis in Pregnancy. 151:516-516. 2009
3 prediction rules, particularly ABCD, identify ED patients who can be discharged with low risk for stroke after TIA. 151. 2009
Vitamin K to Correct Overanticoagulation. 151:435-435. 2009
Comparing the USPSTF and GRADE Approaches to Recommendations. 151:363-363. 2009
Prednisolone, but not valacyclovir, reduced time to complete recovery of facial-nerve function in Bell palsy. 150:JC3-JC3. 2009
What does it take to put an ugly fact through the heart of a beautiful hypothesis?. 150:JC3-JC3. 2009
Telmisartan did not prevent recurrent stroke or major cardiovascular events. 150:JC2-JC2. 2009
A single measure of urinary neutrophil gelatinase-associated lipocalin was accurate for diagnosing acute kidney injury.. 149:13. 2008
A single measure of urinary neutrophil gelatinase–associated lipocalin was accurate for diagnosing acute kidney injury. 149:JC6-JC6. 2008
GRADE: assessing the quality of evidence for diagnostic recommendations. 149:JC6-JC6. 2008
GRADE: assessing the quality of evidence for diagnostic recommendations.. 149:2. 2008
Evidence in context: One person's poison is another's acceptable risk. 149:JC5-JC5. 2008
Evidence in context: one person's poison is another's acceptable risk.. 149:2-3. 2008
Review: Anticoagulation with INRs < 2 or between 3 and 5 increases risk for thromboembolic or hemorrhagic events. 149:JC5-JC5. 2008
Review: psychological interventions prevent depression after stroke.. 149:13. 2008
Correction: Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-analyses. 149:596-596. 2008
Why internal medicine subspecialists and generalists should register for ACP Journal Club PLUS. 149:JC3-JC3. 2008
The Importance of Measuring Executive Function When Studying the Effects of Cognition-Enhancing Agents. 149:359-359. 2008
Why A-level evidence does not make it to clinicians' A-lists: the case of thromboprophylaxis in medical patients. 149:JC2-JC2. 2008
Why A-level evidence does not make it to clinicians' A-lists: the case of thromboprophylaxis in medical patients.. 149:2. 2008
Correction: Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses. 149:219-219. 2008
Age, sex, and functional impairment predicted risk for mortality in incident dementia at 14 years. 149:JC1-JC1. 2008
Evidence-based medicine targets the individual patient. Part 2: Guides and tools for individual decision-making. 149:JC1-JC1. 2008
Age, sex, and functional impairment predicted risk for mortality in incident dementia at 14 years.. 149:13. 2008
Evidence-based medicine targets the individual patient. Part 2: Guides and tools for individual decision-making.. 149:1-2. 2008
Evidence-based medicine targets the individual patient. Part 1: How clinicians can use study results to determine optimal individual care. 148:JC4-JC4. 2008
Evidence-based medicine targets the individual patient. Part 1: how clinicians can use study results to determine optimal individual care.. 148:2. 2008
Intensive insulin therapy and starch (HES 200/0.5) had some risk and no clear benefit in severe sepsis.. 148:4. 2008
Low-dose hydrocortisone did not improve survival in patients with septic shock but reversed shock earlier. 148:JC4-JC4. 2008
Low-dose hydrocortisone did not improve survival in patients with septic shock but reversed shock earlier.. 148:6. 2008
Review: Azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn disease. 148:JC4-JC4. 2008
Review: azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn disease.. 148:9. 2008
Guideline Adaptation: An Appealing Alternative to De Novo Guideline Development. 148:563-563. 2008
6Ts Teaching Tips for evidence-based practitioners*. 148:A9-A9. 2008
Early treatment with prednisolone, but not acyclovir, promoted complete recovery of facial-nerve function in Bell palsy. 148:29-29. 2008
Heparin prophylaxis did not increase mortality and was beneficial in adults with sepsis receiving drotrecogin alfa. 148:32-32. 2008
Addition of graduated compression stockings to fondaparinux did not reduce risk for venous thromboembolism after hip surgery. 148:21-21. 2008
Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin. 147:671-671. 2007
Anticoagulant Prophylaxis for Hospitalized Medical Patients. 147:524-524. 2007
Rituximab for Patients with Idiopathic Thrombocytopenic Purpura. 147:281-281. 2007
Review: Flight times > 8 hours and the presence of risk factors for VTE increase travel-related VTE. 147:7-7. 2007
Ethical Issues in Stopping Randomized Trials Early Because of Apparent Benefit. 146:878-878. 2007
A communication strategy and brochure reduced the burden of bereavement on relatives of patients dying in the intensive care unit. 146:69-69. 2007
Review: Eradication therapy supplemented by probiotics increased eradication rates and reduced side effects in H. pylori infection. 146:63-63. 2007
An abnormal D-dimer test result indicated that anticoagulation should be continued. 146:29-29. 2007
Noninferiority was not shown between stenting and endarterectomy in severe symptomatic carotid stenosis. 146:33-33. 2007
Review: Inhaled insulin provides better glycemic control than oral hypoglycemic agents but not better than subcutaneous insulin. 146:38-38. 2007
Stenting led to more stroke or death than did endarterectomy in symptomatic carotid stenosis ≥ 60%. 146:32-32. 2007
Misunderstandings, misperceptions, and mistakes. 146:A8-A8. 2007
Of studies, syntheses, synopses, summaries, and systems: the “5S” evolution of information services for evidence-based health care decisions. 145:A8-A8. 2006
Oral decontamination with chlorhexidine reduced ventilator-associated pneumonia in high-risk patients. 145:68-68. 2006
Review: A low-protein diet delays end-stage renal disease or death in stage 3 to 5 chronic kidney disease. 145:64-64. 2006
Review: The renoprotective effects of ACE inhibitors and ARBs independent of blood pressure control are uncertain. 145:36-36. 2006
Intensive insulin therapy reduced cardiovascular disease in type 1 diabetes. 144:63-63. 2006
An early invasive strategy was not better than a selectively invasive strategy for acute coronary syndromes. 144:30-30. 2006
The Canadian CT Head Rule was as sensitive as, but more specific than, the New Orleans Criteria for identifying minor head injury. 144:53-53. 2006
A simple risk score predicted 7-day stroke risk after transient ischemic attack. 144:24-24. 2006
An emerging consensus on grading recommendations?. 144:A8-A8. 2006
Management with a pulmonary artery catheter did not reduce all-cause mortality in critically ill patients. 144:21-21. 2006
Moderate-and high-intensity implementation of guidelines increased outpatient care of low-risk pneumonia. 144:80-80. 2006
Vena cava filters reduced long-term risk for pulmonary embolism in proximal deep venous thrombosis. 144:18-18. 2006
Endovascular and open repair did not differ for mortality rates at 2 years in abdominal aortic aneurysm. 143:64-64. 2005
How should clinicians interpret results reflecting the effect of an intervention on composite endpoints: Should I dump this lump?. 143:A8-A8. 2005
Alendronate reduced clinical and radiographic vertebral fractures in postmenopausal women with osteopenia. 143:46-46. 2005
Intensive insulin-glucose infusion regimens with long-term or standard glucose control did not differ for reducing mortality in type 2 diabetes mellitus and MI. 143:43-43. 2005
Low-dose aspirin lowered stroke risk but not risk for MI or cardiovascular death in women. 143:33-33. 2005
Review: Low-dose dopamine does not reduce mortality or need for renal replacement therapy. 143:42-42. 2005
Warfarin was not more effective than aspirin and increased adverse events in symptomatic intracranial arterial stenosis. 143:32-32. 2005
Clinical Experience and Quality of Health Care. 143:85-85. 2005
Patient self-management of anticoagulants reduced arterial thromboembolism and adverse effects. 143:8-8. 2005
Prophylactic coronary artery revascularization before elective vascular surgery did not improve long-term survival. 143:12-12. 2005
Review: Population-based screening for abdominal aortic aneurysm reduces cause-specific mortality in older men. 143:11-11. 2005
Does clinical experience make up for failure to keep up to date?. 142:A8-A8. 2005
Reduced glomerular filtration rate was associated with increased death, cardiovascular events, and hospitalization. 142:50-50. 2005
Renal impairment increased mortality and cardiovascular complications after myocardial infarction. 142:51-51. 2005
Review: Glucocorticoids reduced mortality in sepsis in recent (post-1997) but not previous (pre-1989) trials, or all trials combined. 142:31-31. 2005
Review: Low-dose but not high-dose corticosteroids reduced all-cause mortality in severe sepsis and septic shock. 142:30-30. 2005
Glycemia and Risk for Cardiovascular Disease. 142:227-227. 2005
Finding the gold in MEDLINE: Clinical Queries. 142:A8-A8. 2005
Methylprednisolone caused an increase in death after head injury. 142:5-5. 2005
Rapid measurement of B-type natriuretic peptides reduced time to discharge and treatment costs in patients with acute dyspnea. 142:A14-A14. 2005
Volunteers trained in CPR and use of automated external defibrillators increased survival after out-of-hospital cardiac arrest. 142:2-2. 2005
Fondaparinux was as effective as (noninferior to) enoxaparin in acute symptomatic deep venous thrombosis. 141:74-74. 2004
Perioperative use of atorvastatin reduced cardiovascular events in patients having vascular surgery. 141:64-64. 2004
Low-Molecular-Weight Heparin for Pulmonary Embolism. 141:407-407. 2004
Doubling the dose of inhaled corticosteroids during asthma deterioration did not improve asthma control. 141:37-37. 2004
Fluid resuscitation with albumin or saline in the intensive care unit did not affect 28-day mortality rates. 141:29-29. 2004
Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding. 141:80-80. 2004
Valsartan plus captopril did not improve survival more than captopril alone after myocardial infarction. 141:3-3. 2004
Vasopressin was not better than epinephrine for out-of-hospital cardiac arrest. 141:2-2. 2004
Acpjc.org adds enhanced searching to many other features. 140:A13a-A13a. 2004
Campaign to revitalize academic medicine. 140:A13b-A13b. 2004
Estrogen plus progestin reduced risk for fracture in postmenopausal women. 140:61-61. 2004
Suboptimal Monitoring and Dosing of Unfractionated Heparin. 140:582-582. 2004
High- and moderate-intensity warfarin regimens did not differ for preventing thrombosis in the antiphospholipid antibody syndrome. 140:38-38. 2004
Noninvasive ventilation reduced duration of mechanical ventilation and ICU stay more than conventional weaning. 140:35-35. 2004
34% mortality rate from SARS in critically ill patients at 28 days in Toronto. 140:20-20. 2004
37% mortality rate from SARS in critically ill patients at 28 days in Singapore. 140:21-21. 2004
Patients at the center: In our practice, and in our use of language. 140:A11-A11. 2004
Rapid measurement of B-type natriuretic peptides reduced time to discharge and treatment costs in patients with acute dyspnea/COMMENTARY. 141:35-35. 2004
Enalapril reduced the risk for new-onset diabetes in left ventricular dysfunction. 139:68-68. 2003
Low-intensity warfarin therapy prevented recurrent venous thromboembolism. 139:42-42. 2003
A win–win proposition: help us to build better evidence-based information systems for you. 139:A13-A13. 2003
Review: Debridement using hydrogel seems to be better than standard wound care for healing diabetic foot ulcer. 139:16-16. 2003
Suboptimal Monitoring and Dosing of Unfractionated Heparin in Comparative Studies with Low-Molecular-Weight Heparin. 138:720-720. 2003
Review: MTHFR TT genotype increases risk for coronary heart disease. 138:79-79. 2003
Oral Vitamin K for Warfarin-Associated Coagulopathy. 138:611-611. 2003
Homocysteine-lowering therapy improved outcomes after percutaneous coronary intervention. 138:33-33. 2003
Amlodipine or lisinopril was not better than chlorthalidone in lowering CHD risk in hypertension.. 139. 2003
The Memory Impairment Screen more accurately screened for Alzheimer disease than the 3-word memory test in older adults. 138:25-25. 2003
Colloid Use in the Critically Ill. 137:370-370. 2002
Clonidine and methylphenidate were effective for attention deficit hyperactivity disorder in children with comorbid tics. 137:70-70. 2002
Questioning the Treatment of Venous Thromboembolism. 137:145-145. 2002
Review: Extended out-of-hospital prophylaxis with heparin prevents deep venous thrombosis in elective hip arthroplasty. 137:11-11. 2002
Abciximab plus stenting reduced coronary events in patients with acute myocardial infarction. 136:89-89. 2002
Irbesartan reduced progression of nephropathy caused by type 2 diabetes independent of the effect on blood pressure.. 136:82-84. 2002
Irbesartan was renoprotective in patients with type 2 diabetes, hypertension, and microalbuminuria. 136:82-82. 2002
Cardiovascular Outcomes and Renal Disease. 136:634-634. 2002
Clinical expertise in the era of evidence-based medicine and patient choice.. 136:A11-A14. 2002
Rule-based computerized reminders increased ordering of preventive services in an inpatient setting. 136:74-74. 2002
Review: Albumin administration is not associated with excess mortality in acutely ill patients. 136:2-2. 2002
“Double blind, you are the weakest link—good-bye!”. 136:A11-A11. 2002
Recombinant human activated protein C reduced all-cause mortality in patients with severe sepsis. 135:81-81. 2001
The rocky road: qualitative research as evidence.. 134. 2001
Homocyst(e)ine and Cardiovascular Disease. 132:676-676. 2000
Ventilator-Associated Pneumonia in Critically Ill Patients. 130:1028-1028. 1999
The Ineffectiveness of Immunosuppressive Therapy in Lymphocytic Myocarditis: An Overview. 129:317-317. 1998
Coenzyme A Reductase Inhibitors and Stroke. 129:162-162. 1998
Locating and Appraising Systematic Reviews. 128:323-323. 1998
Using 'Best Evidence' in clinical practice.. 128. 1998
Fish consumption in men decreased nonsudden death from MI. 127:80-80. 1997
Reply: Warfarin: Less May Be Better. 127:333-333. 1997
Splenectomy for Relapsing Thrombotic Thrombocytopenic Purpura. 126:915-915. 1997
Transferring evidence from research into practice: 4. Overcoming barriers to application. 126:A14-A14. 1997
Dietary Calcium and Blood Pressure. 126:492-492. 1997
Subcutaneous tunneling reduced catheter-related sepsis in critically ill patients. 126:42-42. 1997
Transferring evidence from research into practice: 3. Developing evidence-based clinical policy. 126:A14-A14. 1997
Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy. 126:133-133. 1997
Transferring evidence from research into practice: 2. Getting the evidence straight. 126:A14-A14. 1997
Transferring evidence from research into practice: 1. The role of clinical care research evidence in clinical decisions. 125:A14-A14. 1996
Enteral feeding by endoscopic gastrostomy reduced 6-week mortality after dysphagic stroke. 125:5-5. 1996
Beyond ACP Journal Club: how to harness MEDLINE for review articles. 124:A12-A12. 1996
Beyond ACP Journal Club: how to harness MEDLINE for prognosis problems. 123:A12-A12. 1995
Late Relapses in Patients Successfully Treated for Thrombotic Thrombocytopenic Purpura. 122:569-569. 1995
Applying the findings of clinical trials to individual patients. 122:A12-A12. 1995
How should clinicians use the results of randomized trials?. 122:A12-A12. 1995
Beyond ACP Journal Club: how to harness MEDLINE for etiology problems. 121:A10-A10. 1994
Analyzing Computer-based Decision Support Systems. 121:469-469. 1994
Effects of Computer-based Clinical Decision Support Systems on Clinician Performance and Patient Outcome: A Critical Appraisal of Research. 120:135-135. 1994
Efficacy and Cost of Low-Molecular-Weight Heparin Compared with Standard Heparin for the Prevention of Deep Vein Thrombosis after Total Hip Arthroplasty. 119:1105-1105. 1993
Impedance Plethysmography and DVT Diagnosis. 119:246-246. 1993
Clinical judgment was inaccurate for the diagnosis and treatment of ventilator-associated pneumonia in ICU patients who needed mechanical ventilation. 119:22-22. 1993
Eliciting Patient Preferences. 118:76-76. 1993
Subcutaneous compared with intravenous heparin for deep vein thrombosis.. 117:266. 1992
A Consumer's Guide to Subgroup Analyses. 116:78-78. 1992
Loose Connections between Peer-Reviewed Clinical Journals and Clinical Practice. 113:724-724. 1990
More Informative Abstracts Revisited. 113:69-69. 1990
Superiority of Alternating Non-Cross-Resistant Chemotherapy in Extensive Small Cell Lung Cancer. 107:451-451. 1987
Bicarbonate in Severe Lactic Acidosis. 107:258-258. 1987
A Proposal for More Informative Abstracts of Clinical Articles. 106:598-598. 1987
Correction: How to Keep Up with the Medical Literature. 106:174-174. 1987
Canadian Cancer Care: Organizational Models. 105:932-932. 1986
Searching the Medical Literature. 105:472-472. 1986
Computer Searching of the Medical Literature. 104:723-723. 1986
Platelet-Aggregating Factor in Thrombotic Thrombocytopenic Purpura. 102:560-560. 1985
Malignant Lymphoma Presenting as Kaposi's Sarcoma in a Homosexual Man with the Acquired Immunodeficiency Syndrome. 102:338-338. 1985
Lidocaine Therapy with an Exponentially Declining Infusion. 101:632-632. 1984
Choice of Platelet Anticoagulants. 100:613-613. 1984
Tamoxifen and Metastatic Breast Cancer. 89:721-721. 1978
Thrombolytic Therapy and Fatal Pulmonary Emboli. 75:140-140. 1971
Death and Disability in Drug Addiction and Abuse. 67:205-205. 1967
THE MANAGEMENT OF BILIARY TRACT DISORDERS IN PATIENTS WITH HEART DISEASE. 39:484-484. 1953

ACP journal club Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)